Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rosendaal

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Hematology|September 1, 1999
ThrombophiliaM V Huisman, F Rosendaal
British Journal of Haematology|October 29, 2000
Factor V Leiden: the venous thrombotic risk in thrombophilic familiesR Lensen, F Rosendaal, J Vandenbroucke, et al.
Lancet (London, England)|October 30, 1993
Factor VIII inhibitorK Peerlinck, J Vermylen, F Rosendaal, et al.
Social Science & Medicine (1982)|June 20, 2007
Making a bad thing worse: effects of communication of results of an epidemiological study after an aviation disasterM Verschuur, P Spinhoven, A van Emmerik, et al.
Critical Care Medicine|April 2, 2008
Severe hypoglycemia in critically ill: risk and outcomesT M Vriesendorp, J H DeVries, F Rosendaal, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2005
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)A E A Dahm, T O Andersen, F Rosendaal, et al.
Journal of Thrombosis and Haemostasis : JTH|August 7, 2016
Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTHA Iorio, A M Barbara, F Bernardi, et al.
Thrombosis and Haemostasis|April 20, 2001
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and HaemostasisG C White, F Rosendaal, L M Aledort, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2013
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trialM Raps, F Rosendaal, B Ballieux, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2012
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptivesM Raps, F Helmerhorst, K Fleischer, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Hematology|September 1, 1999
ThrombophiliaM V Huisman, F Rosendaal
British Journal of Haematology|October 29, 2000
Factor V Leiden: the venous thrombotic risk in thrombophilic familiesR Lensen, F Rosendaal, J Vandenbroucke, et al.
Lancet (London, England)|October 30, 1993
Factor VIII inhibitorK Peerlinck, J Vermylen, F Rosendaal, et al.
Social Science & Medicine (1982)|June 20, 2007
Making a bad thing worse: effects of communication of results of an epidemiological study after an aviation disasterM Verschuur, P Spinhoven, A van Emmerik, et al.
Critical Care Medicine|April 2, 2008
Severe hypoglycemia in critically ill: risk and outcomesT M Vriesendorp, J H DeVries, F Rosendaal, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2005
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)A E A Dahm, T O Andersen, F Rosendaal, et al.
Journal of Thrombosis and Haemostasis : JTH|August 7, 2016
Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTHA Iorio, A M Barbara, F Bernardi, et al.
Thrombosis and Haemostasis|April 20, 2001
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and HaemostasisG C White, F Rosendaal, L M Aledort, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2013
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trialM Raps, F Rosendaal, B Ballieux, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2012
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptivesM Raps, F Helmerhorst, K Fleischer, et al.
Pageof 1